Related Experiment Video
Updated: Jun 15, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Update on radiation-based therapies for prostate cancer
1Department of Radiation Oncology, University of Maryland School of Medicine, University of Maryland Medical Center, Baltimore, Maryland 21201, USA. ykwok@umm.edu
Current Opinion in Oncology
|February 27, 2010
Summary
Radiation dose escalation is effective for prostate cancer. New techniques like hypofractionation and advanced technologies require further validation for improved outcomes and reduced toxicity.
Area of Science:
- Oncology
- Radiation Oncology
- Urology
Background:
- Radiation therapy is a cornerstone in prostate cancer management.
- Adjuvant radiation therapy is standard for pT3 disease or positive margins post-prostatectomy, based on SWOG 8794 trial data.
Purpose of the Study:
- To summarize recent advancements in radiation-based therapies for prostate cancer.
- To highlight emerging techniques and technologies in radiation oncology for prostate cancer.
Main Methods:
- Review of recent developments in radiation therapy for prostate cancer.
- Analysis of clinical trial outcomes and technological advancements.
Main Results:
- Radiation dose escalation is a validated, effective strategy.
- Adjuvant radiation therapy offers survival benefits for specific patient groups.
- Hypofractionation and stereotactic body radiation therapy are increasingly used but lack large-scale trial validation.
- New technologies like Calypso 4D and VMAT show potential for improved accuracy, efficacy, and reduced toxicity.
Conclusions:
- Radiation therapy remains crucial for prostate cancer treatment.
- Prospective validation is essential for novel strategies including hypofractionation, SBRT, VMAT, and Calypso tumor tracking.
